User Tools
4dn:nih_only_area:eu_4dn
Differences
This shows you the differences between two versions of the page.
| Next revision | Previous revision | ||
|
4dn:nih_only_area:eu_4dn [2019/01/23 15:54] rcalandrelli created |
4dn:nih_only_area:eu_4dn [2025/04/22 16:21] (current) |
||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ====== EU 4DN ====== | ====== EU 4DN ====== | ||
| - | **<font 20px/inherit;;inherit;;inherit>EU 4DN activities</font>** | + | **EU 4DN activities ** |
| - | <font 20px/inherit;;inherit;;inherit>provided by Ana Pombo:</font> | + | provided by Ana Pombo: |
| One formal initiative ([[https://www.google.com/url?q=https://www.4dnucleome.eu/&sa=D&sntz=1&usg=AFQjCNG_CP-HRKlgTDXdMem_IIm0V6YJ0g|https://www.4dnucleome.eu/]]) was directly linked with country-wide coordinated lobbying for top level EU funding. 4DN-EU scored well in the first round, but we were asked to merge with another group, with a strong focus on single cell studies. The joint EU Flagship consortium is called LifeTime ([[https://www.google.com/url?q=https://lifetime-fetflagship.eu/&sa=D&sntz=1&usg=AFQjCNGMo9JftqXHePz4K-qqaXQv4MNWjg|https://lifetime-fetflagship.eu]]/), co-led by MDC with Curie (N. Rajewsky and Genevieve Almouzni). If funded we will get 1-yr top level funding to create the initiatives that would become priority funding schemes from 2020. | One formal initiative ([[https://www.google.com/url?q=https://www.4dnucleome.eu/&sa=D&sntz=1&usg=AFQjCNG_CP-HRKlgTDXdMem_IIm0V6YJ0g|https://www.4dnucleome.eu/]]) was directly linked with country-wide coordinated lobbying for top level EU funding. 4DN-EU scored well in the first round, but we were asked to merge with another group, with a strong focus on single cell studies. The joint EU Flagship consortium is called LifeTime ([[https://www.google.com/url?q=https://lifetime-fetflagship.eu/&sa=D&sntz=1&usg=AFQjCNGMo9JftqXHePz4K-qqaXQv4MNWjg|https://lifetime-fetflagship.eu]]/), co-led by MDC with Curie (N. Rajewsky and Genevieve Almouzni). If funded we will get 1-yr top level funding to create the initiatives that would become priority funding schemes from 2020. | ||
| Line 12: | Line 12: | ||
| More locally, in Germany, Stefan Mundlos, Argyris Papantonis, Eileen Furlong and I, co-coordinate an DFG Priority Program SPP2202, on “Spatial genome architecture in development and disease”, which is currently receiving applications. The focus is on mechanisms, disease and development, novel technologies and data integration. We don’t yet have a website, nor the final membership (~20 groups), but the call can be found here: [[http://www.google.com/url?q=http://www.dfg.de/foerderung/info_wissenschaft/info_wissenschaft_18_25/index.html&sa=D&sntz=1&usg=AFQjCNHXp34oZ9xe7CvmOKCsC02vA_9p1w|http://www.dfg.de/foerderung/info_wissenschaft/info_wissenschaft_18_25/index.html]]. Funded projects will be decided early in 2019. | More locally, in Germany, Stefan Mundlos, Argyris Papantonis, Eileen Furlong and I, co-coordinate an DFG Priority Program SPP2202, on “Spatial genome architecture in development and disease”, which is currently receiving applications. The focus is on mechanisms, disease and development, novel technologies and data integration. We don’t yet have a website, nor the final membership (~20 groups), but the call can be found here: [[http://www.google.com/url?q=http://www.dfg.de/foerderung/info_wissenschaft/info_wissenschaft_18_25/index.html&sa=D&sntz=1&usg=AFQjCNHXp34oZ9xe7CvmOKCsC02vA_9p1w|http://www.dfg.de/foerderung/info_wissenschaft/info_wissenschaft_18_25/index.html]]. Funded projects will be decided early in 2019. | ||
| + | |||
| + | ------------------------------------------------------------------------------------------ | ||
| + | |||
| + | {{medialist>4dn:nih_only_area:eu_4DN:}} | ||
4dn/nih_only_area/eu_4dn.1548287699.txt.gz · Last modified: 2025/04/22 16:21 (external edit)